Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-28
2006-03-28
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S443000
Reexamination Certificate
active
07019022
ABSTRACT:
The present invention provides substituted tetrahydrocarbazole and cyclopentanoindole derivatives as antagonists of DP receptor, and as such are useful for the treatment of prostaglandin D2 mediated diseases such as rhinitis, asthma and nasal congestion.
REFERENCES:
patent: 4808608 (1989-02-01), Guindon et al.
patent: 6410583 (2002-06-01), Labelle et al.
patent: 2003/0158246 (2003-08-01), Berthelette et al.
patent: WO 2004/103970 (2004-12-01), None
patent: WO 2005/013985 (2005-02-01), None
Beaulieu Christian
Guay Daniel
Wang Zhaoyin
Zamboni Robert
Merck Frosst Canada & Co.
Rose David L.
Saeed Kamal A.
Yang Mollie M.
LandOfFree
Substituted tetrahydrocarbazole and cyclopentanoindole... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetrahydrocarbazole and cyclopentanoindole..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetrahydrocarbazole and cyclopentanoindole... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3536267